Comments on: OncoTherapy Science (OTS) announced on February 1 that it has signed a joint research agreement with Carna Biosciences (CARNA) and CrystalGenomics (CG).

Comments on: OncoTherapy Science (OTS) announced on February 1 that it has signed a joint research agreement with Carna Biosciences (CARNA) and CrystalGenomics (CG). http://www.bioscreening.net/2006/02/01/ms-sabatinis-background-includes-positions-with-incyte-where-she-was-the-director-of-product-development-and-delivered-the-first-genomic-microbial-database-product-pathoseq-from-concept-to-release-in/ BioScreening news and events hourly 1 http://wordpress.org/?v=3.3